Toll-like receptor alterations in myelodysplastic syndrome-Reference-Cited by-同舟云学术

Toll-like receptor alterations in myelodysplastic syndrome

Published:2013-06-14 Issue:9 Volume:27 Page:1832-1840
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Wei Y,Dimicoli S,Bueso-Ramos C,Chen R,Yang H,Neuberg D,Pierce S,Jia Y,Zheng H,Wang H,Wang X,Nguyen M,Wang S A,Ebert B,Bejar R,Levine R,Abdel-Wahab O,Kleppe M,Ganan-Gomez I,Kantarjian H,Garcia-Manero G

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu2013180.pdf

Reference29 articles.

1. Tefferi A, Vardiman JW . Myelodysplastic syndromes. N Engl J Med 2009; 361: 1872–1885.

2. Wei Y, Chen R, Dimicoli S, Bueso-Ramos C, Neuberg D, Pierce S et al. Global H3K4me3 genome mapping reveals alterations of innate immunity signaling and overexpression of JMJD3 in human myelodysplastic syndrome CD34+ cells. Leukemia 2013; e-pub ahead of print 29 March 2013 doi:10.1038/leu.2013.91.

3. Akira S, Uematsu S, Takeuchi O . Pathogen recognition and innate immunity. Cell 2006; 124: 783–801.

4. De Santa F, Totaro MG, Prosperini E, Notarbartolo S, Testa G, Natoli G . The histone H3 lysine-27 demethylase Jmjd3 links inflammation to inhibition of polycomb-mediated gene silencing. Cell 2007; 130: 1083–1094.

5. Li H, Durbin R . Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 2009; 25: 1754–1760.

Cited by 138 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging interleukin-1 receptor-associated kinase 4 (IRAK4) inhibitors or degraders as therapeutic agents for autoimmune diseases and cancer;Acta Pharmaceutica Sinica B;2024-09

2. Research and clinical updates on IRAK4 and its roles in inflammation and malignancy: themes and highlights from the 1st symposium on IRAK4 in cancer;Frontiers in Hematology;2024-02-15

3. Alternative splicing and related RNA binding proteins in human health and disease;Signal Transduction and Targeted Therapy;2024-02-02

4. Toll-Like Receptor 4, 2, and Interleukin 1 Receptor Associated Kinase4: Possible Diagnostic Biomarkers in Myelodysplastic Syndrome Patients;Advanced Biomedical Research;2024-02

5. Clonal Hematopoiesis, Inflammation, and Hematologic Malignancy;Annual Review of Pathology: Mechanisms of Disease;2024-01-24